Klein BS - Search Results

1

Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity.

Deepe GS Jr, Wüthrich M, Klein BS. Deepe GS Jr, et al. Among authors: klein bs. Med Mycol. 2005 Aug;43(5):381-9. doi: 10.1080/13693780500245875. Med Mycol. 2005. PMID: 16178365 Review.

2

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.

Wüthrich M, Chang WL, Klein BS. Wüthrich M, et al. Among authors: klein bs. Infect Immun. 1998 Nov;66(11):5443-9. doi: 10.1128/IAI.66.11.5443-5449.1998. Infect Immun. 1998. PMID: 9784555 Free PMC article.

3

Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.

Brandhorst TT, Wüthrich M, Warner T, Klein B. Brandhorst TT, et al. J Exp Med. 1999 Apr 19;189(8):1207-16. doi: 10.1084/jem.189.8.1207. J Exp Med. 1999. PMID: 10209038 Free PMC article.

4

Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis.

Wüthrich M, Klein BS. Wüthrich M, et al. Among authors: klein bs. J Infect Dis. 2000 May;181(5):1720-8. doi: 10.1086/315473. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823774

5

Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection.

Wüthrich M, Finkel-Jiminez BE, Klein BS. Wüthrich M, et al. Among authors: klein bs. Infect Immun. 2000 Dec;68(12):7172-4. doi: 10.1128/IAI.68.12.7172-7174.2000. Infect Immun. 2000. PMID: 11083850 Free PMC article.

6

Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Wüthrich M, Filutowicz HI, Klein BS. Wüthrich M, et al. Among authors: klein bs. J Clin Invest. 2000 Dec;106(11):1381-9. doi: 10.1172/JCI11037. J Clin Invest. 2000. PMID: 11104791 Free PMC article.

7

The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis.

Finkel-Jimenez B, Wüthrich M, Brandhorst T, Klein BS. Finkel-Jimenez B, et al. Among authors: klein bs. J Immunol. 2001 Feb 15;166(4):2665-73. doi: 10.4049/jimmunol.166.4.2665. J Immunol. 2001. PMID: 11160330

8

BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms.

Finkel-Jimenez B, Wüthrich M, Klein BS. Finkel-Jimenez B, et al. Among authors: klein bs. J Immunol. 2002 Jun 1;168(11):5746-55. doi: 10.4049/jimmunol.168.11.5746. J Immunol. 2002. PMID: 12023375

9

Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts.

Wüthrich M, Filutowicz HI, Warner T, Klein BS. Wüthrich M, et al. Among authors: klein bs. J Immunol. 2002 Dec 15;169(12):6969-76. doi: 10.4049/jimmunol.169.12.6969. J Immunol. 2002. PMID: 12471131

10

A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis.

Brandhorst T, Wüthrich M, Finkel-Jimenez B, Klein B. Brandhorst T, et al. Mol Microbiol. 2003 Apr;48(1):53-65. doi: 10.1046/j.1365-2958.2003.03415.x. Mol Microbiol. 2003. PMID: 12657044 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters